Koers Ampliphi Biosciences Corp OTC Bulletin Board
Aandelen
APHB
US03211P1030
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2024 * | 4,54 mln. 4,18 mln. | Omzet 2025 * | 2,75 mln. 2,54 mln. | Marktkapitalisatie | 98,34 mln. 90,68 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -72 mln. -66,39 mln. | Nettowinst (verlies) 2025 * | -67 mln. -61,78 mln. | EV/omzet 2024 * | 21,7 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 35,8 x |
K/w-verhouding 2024 * |
-1,43
x | K/w-verhouding 2025 * |
-2,09
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 29,72% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Deborah Birx
CEO | Chief Executive Officer | 68 | 11-07-23 |
Mina Pastagia
CTO | Chief Tech/Sci/R&D Officer | - | 26-10-20 |
Bryan Kadotani
PRN | Corporate Officer/Principal | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 64 | 12-02-20 | |
Joseph Patti
BRD | Director/Board Member | 60 | 09-05-19 |
Jules Haimovitz
BRD | Director/Board Member | 73 | 01-04-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+43,36% | 54,64 mld. | |
-5,31% | 39,92 mld. | |
+37,52% | 38,82 mld. | |
+14,75% | 26,86 mld. | |
-12,56% | 26,22 mld. | |
-22,45% | 18,78 mld. | |
+25,12% | 12,21 mld. | |
+0,04% | 12,16 mld. | |
+26,04% | 11,94 mld. |
- Beurs
- Aandelen
- Koers ARMP
- Koers APHB